| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.042 | 0.8 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.044 | 0.8 |